|
1
|
Sprung CL and Reinhart K: Definitions for
sepsis and septic shock. JAMA. 316:456–457. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brun-Buisson C, Meshaka P, Pinton P and
Vallet B; EPISEPSIS Study Group: EPISEPSIS: A reappraisal of the
epidemiology and outcome of severe sepsis in French intensive care
units. Intensive Care Med. 30:580–588. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gaieski DF, Edwards JM, Kallan MJ and Carr
BG: Benchmarking the incidence and mortality of severe sepsis in
the United States. Crit Care Med. 41:1167–1174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zaky A, Deem S, Bendjelid K and Treggiari
MM: Characterization of cardiac dysfunction in sepsis: An ongoing
challenge. Shock. 41:12–24. 2014. View Article : Google Scholar
|
|
5
|
Lush CW and Kvietys PR: Microvascular
dysfunction in sepsis. Microcirculation. 7:83–101. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scarabelli T, Stephanou A, Rayment N,
Pasini E, Comini L, Curello S, Ferrari R, Knight R and Latchman D:
Apoptosis of endothelial cells precedes myocyte cell apoptosis in
ischemia/reperfusion injury. Circulation. 104:253–256. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salmon AH and Satchell SC: Endothelial
glycocalyx dysfunction in disease: Albuminuria and increased
microvascular permeability. J Pathol. 226:562–574. 2012. View Article : Google Scholar
|
|
8
|
Liu Y, Lian K, Zhang L, Wang R, Yi F, Gao
C, Xin C, Zhu D, Li Y, Yan W, et al: TXNIP mediates NLRP3
inflammasome activation in cardiac microvascular endothelial cells
as a novel mechanism in myocardial ischemia/reperfusion injury.
Basic Res Cardiol. 109:4152014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu CE, Zhang MY, Zou CW and Guo L:
Evaluation of the pharmacological function of ulinastatin in
experimental animals. Molecules. 17:9070–9080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang N, Liu X, Zheng X, Cao H, Wei G, Zhu
Y, Fan S, Zhou H and Zheng J: Ulinastatin is a novel candidate drug
for sepsis and secondary acute lung injury, evidence from an
optimized CLP rat model. Int Immunopharmacol. 17:799–807. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao YZ, Tu YY, Chen X, Wang BL, Zhong YX
and Liu MH: Protective effect of Ulinastatin against murine models
of sepsis: Inhibition of TNF-α and IL-6 and augmentation of IL-10
and IL-13. Exp Toxicol Pathol. 64:543–547. 2012. View Article : Google Scholar
|
|
12
|
Huang N, Wang F, Wang Y, Hou J, Li J and
Deng X: Ulinastatin improves survival of septic mice by suppressing
inflammatory response and lymphocyte apoptosis. J Surg Res.
182:296–302. 2013. View Article : Google Scholar
|
|
13
|
Karnad DR, Bhadade R, Verma PK, Moulick
ND, Daga MK, Chafekar ND and Iyer S: Intravenous administration of
ulinastatin (human urinary trypsin inhibitor) in severe sepsis: A
multicenter randomized controlled study. Intensive Care Med.
40:830–838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bashir F, Rather MA, Saleem B and Hamid A:
a prospective, randomized study using ulinastatin for the treatment
of patients with severe sepsis. JEMDS. 3:12241–12246. 2014.
View Article : Google Scholar
|
|
15
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Johnson R: Long non-coding RNAs in
Huntington's disease neurodegeneration. Neurobiol Dis. 46:245–254.
2012. View Article : Google Scholar
|
|
17
|
Congrains A, Kamide K, Oguro R, Yasuda O,
Miyata K, Yamamoto E, Kawai T, Kusunoki H, Yamamoto H, Takeya Y, et
al: Genetic variants at the 9p21 locus contribute to
atherosclerosis through modulation of ANRIL and CDKN2A/B.
Atherosclerosis. 220:449–455. 2012. View Article : Google Scholar
|
|
18
|
Spizzo R, Almeida MI, Colombatti A, Calin
GA and Martin L: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo F, Li Y, Liu Y, Wang J, Li Y and Li G:
Inhibition of metastasis-associated lung adenocarcinoma transcript
1 in CaSki human cervical cancer cells suppresses cell
proliferation and invasion. Acta Biochim Biophys Sin (Shanghai).
42:224–229. 2010. View Article : Google Scholar
|
|
20
|
Brooks HF, Moss RF, Davies NA, Jalan R and
Davies DC: Caecal ligation and puncture induced sepsis in the rat
results in increased brain water content and perimicrovessel
oedema. Metab Brain Dis. 29:837–843. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia JB, Liu GH, Chen ZY, Mao CZ, Zhou DC,
Wu HY, Park KS, Zhao H, Kim SK, Cai DQ, et al: Hypoxia/ischemia
promotes CXCL10 expression in cardiac microvascular endothelial
cells by NFκB activation. Cytokine. 81:63–70. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang FY, Fang B, Qiang XH, Yu TO, Zhong
JR, Cao J and Zhou LX: The efficacy and immunomodulatory effects of
ulinastatin and thymosin α1 for sepsis: A systematic review and
meta-analysis. Biomed Res Int. 2016:95084932016.
|
|
23
|
Tsoyi K, Lee TY, Lee YS, Kim HJ, Seo HG,
Lee JH and Chang KC: Heme-oxygenase-1 induction and carbon
monoxide-releasing molecule inhibit lipopolysaccharide
(LPS)-induced high-mobility group box 1 release in vitro and
improve survival of mice in LPS-and cecal ligation and
puncture-induced sepsis model in vivo. Mol Pharmacol. 76:173–182.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Djoumerska-Alexieva I, Pashova S, Vassilev
T and Pashov A: The protective effect of modified intravenous
immunoglobulin in LPS sepsis model is associated with an increased
IRA B cells response. Autoimmun Rev. 12:653–656. 2013. View Article : Google Scholar
|
|
25
|
Lee WL and Slutsky AS: Sepsis and
endothelial permeability. N Engl J Med. 363:689–691. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Janicek A, Tharakan B, Sawant DA, Hunter
FA and Childs EW: Lipopolysaccharide-induced endothelial cell
hyperpermeability: Role of mitochondrial apoptotic signaling
pathway. J Surg Res. 172:3302012. View Article : Google Scholar
|
|
27
|
Hu CL, Xia JM, Cai J, Li X, Liao XX, Li H,
Zhan H, Dai G and Jing XL: Ulinastatin attenuates oxidation,
inflammation and neural apoptosis in the cerebral cortex of adult
rats with ventricular fibrillation after cardiopulmonary
resuscitation. Clinics (Sao Paulo). 68:1231–1238. 2013. View Article : Google Scholar
|
|
28
|
Miura M, Sugiura T, Aimi Y, Yasuda K, Ito
S, Baba E and Katsuya H: Effects of ulinastatin on PMNL and
vascular endothelial injury in patients undergoing open heart
surgery with CPB. Masui. 47:29–35. 1998.In Japanese. PubMed/NCBI
|
|
29
|
Li G, Li T, Li Y, Cai S, Zhang Z, Zeng Z,
Wang X, Gao Y, Li Y and Chen Z: Ulinastatin inhibits
oxidant-induced endothelial hyperpermeability and apoptotic
signaling. Int J Clin Exp Pathol. 7:7342–7350. 2014.
|
|
30
|
Lin B, Liu Y, Li T, Zeng K, Cai S, Zeng Z,
Lin C, Chen Z and Gao Y: Ulinastatin mediates protection against
vascular hyperpermeability following hemorrhagic shock. Int J Clin
Exp Pathol. 8:7685–7693. 2015.PubMed/NCBI
|
|
31
|
Atlante A, Calissano P, Bobba A, Azzariti
A, Marra E and Passarella S: Cytochrome c is released from
mitochondria in a reactive oxygen species (ROS)-dependent fashion
and can operate as a ROS scavenger and as a respiratory substrate
in cerebellar neurons undergoing excitotoxic death. J Biol Chem.
275:37159–37166. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sinha K, Das J, Pal PB and Sil PC:
Oxidative stress: The mitochondria-dependent and
mitochondria-independent pathways of apoptosis. Arch Toxicol.
87:1157–1180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Childs EW, Tharakan B, Hunter FA, Tinsley
JH and Cao X: Apoptotic signaling induces hyperpermeability
following hemorrhagic shock. Am J Physiol Heart Circ Physiol.
292:H3179–H3189. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu C, Yang M, Tian J, Wang X and Li Z:
MALAT-1: a long non-coding RNA and its important 3′ end functional
motif in colorectal cancer metastasis. Int J Oncol. 39:169–175.
2011.PubMed/NCBI
|
|
37
|
Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F,
Wei M, Shen J, Hou J, Gao X, et al: Long noncoding RNA MALAT-1 is a
new potential therapeutic target for castration resistant prostate
cancer. J Urol. 190:2278–2287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1 - a paradigm for long noncoding RNA function in cancer. J
Mol Med (Berl). 91:791–801. 2013. View Article : Google Scholar
|
|
39
|
Bachmann IM, Halvorsen OJ, Collett K,
Stefansson IM, Straume O, Haukaas SA, Salvesen HB, Otte AP and
Akslen LA: EZH2 expression is associated with high proliferation
rate and aggressive tumor subgroups in cutaneous melanoma and
cancers of the endometrium, prostate, and breast. J Clin Oncol.
24:268–273. 2006. View Article : Google Scholar
|
|
40
|
Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani
RS, Tomlins SA, Mehra R, Laxman B, Cao X, Yu J, et al: Repression
of E-cadherin by the polycomb group protein EZH2 in cancer.
Oncogene. 27:7274–7284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang D, Ding L, Wang L, Zhao Y, Sun Z,
Karnes RJ, Zhang J and Huang H: LncRNA MALAT1 enhances oncogenic
activities of EZH2 in castration-resistant prostate cancer.
Oncotarget. 6:41045–41055. 2015.PubMed/NCBI
|
|
42
|
Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie
Y, Li S, Tang G, Tang H and He X: MicroRNA-124 inhibits
proliferation and induces apoptosis by directly repressing EZH2 in
gastric cancer. Mol Cell Biochem. 392:153–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jiao F, Hu H, Yuan C and Wang L, Jiang W,
Jin Z, Guo Z and Wang L: Elevated expression level of long
noncoding RNA MALAT-1 facilitates cell growth, migration and
invasion in pancreatic cancer. Oncol Rep. 32:2485–2492.
2014.PubMed/NCBI
|
